1

2011 Parkinson Disease ActivityFinal Metrics

August 28, 2012

2

Teva-Supported PD Activityon Medscape Education Neurology

3

Physicians Allied Health

ActivityLaunch

DateLearners

CME/ CE Test Takers

Neuros PCPs Total MDs Nurses PA/ NP Total HCPs

Disease Modification in Parkinson Disease: Are We There Yet?www.medscape.org/viewarticle/745018

6/24/11 9,300 1,521 4,247 1,9047,548

(252% of guarantee)

254 253 1,680

Through July 31, 2011

Teva-Supported PD Activity on Medscape Education NeurologyParticipation

Through July 31, 2012

4

Teva-Supported PD Activity on Medscape Education Neurology High Satisfaction

Through July 31, 2012

5

Teva-Supported PD Activity on Medscape Education Neurology Improved Performance

Through July 31, 2012

6

Teva-Supported PD Activity on Medscape Education Neurology Perceived Barriers to Improved Performance

Through July 31, 2012

7

Does Effective Online Education Make a Difference? Estimated Impact of the Teva-Supported PD Activity on Patient Care

Factors Projected Impact Source/Calculation

Estimated number of Americans suffering from PD 500,000

National Institute of Neurological Diseases and Stroke/NIH

http://www.ninds.nih.gov/disorders/parkinsons_disease/parkinsons_disease_backgrounder.htm

Estimated number of neurologists 13,366 AMA database

Average number of potential PD patients seen per clinician (estimated) 37 Total patients with MS/estimated neurologists

Neurologist learners/interactions for activity (through 7/31/12) 4,247 Medscape metrics report

An average of 63% of neurologist learners planned to make changes to their practice (modify their treatment plans and/or change their screening/prevention practice after participating in the activity), reflecting expected impact of the activity

2,675 Medscape metrics report

79% of neurologist learners are very/somewhat committed to making changes

2,113 Medscape metrics report

The number of patients with PC expected to have improved outcomes as a direct result of the Disease Modification in Parkinson Disease: Are We There Yet? Activity

78,208(~16% of all patients

with PD)

# of neurologist learners who are expecting to change their practice and are committed to

making a change (2,113) x the average number patients with PD per neurologist (37)

Through July 31, 2012

8

Teva-Supported PD Activity on Medscape Education NeurologyCost Effective Education

Reach Cost Per…

Readers 9,300$8.87

per clinician reader

Neurologist Readers

4,247 $17.07

PatientsEstimated

78,208

~$1.05 per patient with improved

outcomes

Through July 31, 2012

9

Overall PD Activity ImpactSummary of Impact vs. Educational Goals

Educational Goal Combined Impact

Strong reach to target audience members Over 9,300 clinician interactions to date

Strong impact on knowledge and behavior

Making a strong impact on their knowledge and behavior

• An average of 63% of clinician readers planned to modify their treatment plans and/or change their screening/prevention practice after participating in the activity

• An average of 79% of readers are very/somewhat committed to making changes

Estimated number of patients with improved outcomes as a result of clinician education

Over 78,208 patients, 16% of all patients with PD

Be cost-effective

Extremely cost-effective

• $8.87 per clinician reader

• $17.07 per neurologist reader

• ~$1.05 per patient with improved outcomes

Through July 31, 2012